Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Sep 1;38(33):2532-2546.
doi: 10.1093/eurheartj/ehx248.

Global position paper on cardiovascular regenerative medicine

Francisco Fernández-Avilés  1   2 , Ricardo Sanz-Ruiz  1   2 , Andreu M Climent  1   2 , Lina Badimon  2   3 , Roberto Bolli  4 , Dominique Charron  5 , Valentin Fuster  2   6   7 , Stefan Janssens  8 , Jens Kastrup  9 , Hyo-Soo Kim  10 , Thomas F Lüscher  11 , John F Martin  12 , Philippe Menasché  13 , Robert D Simari  14 , Gregg W Stone  15 , Andre Terzic  16 , James T Willerson  17 , Joseph C Wu  18 ; TACTICS (Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes) Writing Group; Authors/Task Force Members. Chairpersons; Basic Research Subcommittee; Translational Research Subcommittee; Challenges of Cardiovascular Regenerative Medicine Subcommittee; Tissue Engineering Subcommittee; Delivery, Navigation, Tracking and Assessment Subcommittee; Clinical Trials Subcommittee; Regulatory and funding strategies subcommittee; Delivery, Navigation, Tracking and Assessment Subcommittee
Collaborators, Affiliations
Review

Global position paper on cardiovascular regenerative medicine

Francisco Fernández-Avilés et al. Eur Heart J. .

Erratum in

No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic representation of cardiovascular regenerative advanced therapy medicinal products according to the pre/clinical phase of development. ADSC, adipose tissue-derived stem cells; BMMNC, bone marrow mononuclear cells; BM-MSC, bone marrow-derived mesenchymal stem cells; CDC, cardiosphere-derived cells; CPC, cardiac progenitor cells; CSC, cardiac stem cells; EPC, endothelial progenitor cells; ESC, embryonic stem cells; iPSC, induced pluripotent stem cells; MSC, mesenchymal stem cells; SM, skeletal myoblasts.
Figure 2
Figure 2
Flow-chart of translational research.
Figure 3
Figure 3
Supply chain of cardiac regenerative advanced therapy medicinal products.
See this image and copyright information in PMC

References

    1. Bergmann O, Zdunek S, Felker A, Salehpour M, Alkass K, Bernard S, Sjostrom SL, Szewczykowska M, Jackowska T, Dos Remedios C, Malm T, Andrä M, Jashari R, Nyengaard JR, Possnert G, Jovinge S, Druid H, Frisén J.. Dynamics of cell generation and turnover in the human heart. Cell 2015;161:1566–1575. - PubMed
    1. Sanz-Ruiz R, Bolli R, Gersh BJ, Janssens S, Menasché P, Perin EC, Taylor DA, Terzic A, Willerson F, Fernández-Avilés F.. The TACTICS intitiative: time for a global alliance on cardiovascular regenerative medicine. Eur Heart J 2016;37:2208–2211. - PubMed
    1. Aguirre A, Sancho-Martinez I, Izpisua Belmonte JC.. Reprogramming toward heart regeneration: stem cells and beyond. Cell Stem Cell 2013;12:275–284. - PubMed
    1. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, Anversa P.. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001;344:1750–1757. - PubMed
    1. Kikuchi K, Poss KD.. Cardiac regenerative capacity and mechanisms. Annu Rev Cell Dev Biol 2012;28:719–741. - PMC - PubMed

Publication types